List of opportunities awaiting VMDVMD – Opportunities that should expand the PE multiple
· Return to core revenue growth. Interrupted by COVID
· Making an acquisition in the COPD line of business. Long overdue!
· Announcing a new core line of business. Management has shown versatility for short-term opportunities and suggests it is ready for a new addition through acquisition.
· Paying cash for the acquisition instead of issuing a share offering. Cash arose from the sale of PPE in Q2 2020.
· Signing of a VA contract. Long overdue!
· Higher margins from the expansion of the virtual visits by RTs. Model developed in response to COVID
· Access to traditional lines of referrals as COVID eases. Interrupted by COVID.
· Evolving new lines of referral through software applications that present added value to physician groups. Model developed in response to COVID
Any others?